A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone

Fertility and Sterility

Volumn 97, Issue 6, 2012, Pages 1351-1358

  Boostanfar, Robert ^a   Mannaerts, Bernadette ^b   Pang, Samuel ^c   Fernandez Sanchez, Manuel ^d   Witjes, Han ^b   Devroey, Paul ^e  

^a Huntington Reproductive Center   (United States)

^b MSD   (Netherlands)

^c Reproductive Science Center of New England   (United States)

^d IVI Sevilla   (Spain)

^e CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

corifollitropin alfa; cumulative pregnancy rates; Europe; GnRH antagonist; Live birth rates; North America

Indexed keywords

CORIFOLLITROPIN ALFA; FOLLITROPIN;

ADULT; ARTICLE; BIRTH RATE; CONTROLLED STUDY; CRYOPRESERVATION; DOUBLE BLIND PROCEDURE; ECTOPIC PREGNANCY; EMBRYO TRANSFER; EUROPE; FEMALE; FERTILIZATION IN VITRO; FOLLOW UP; FREEZE THAWING; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE PREGNANCY; NORTH AMERICA; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPONTANEOUS ABORTION;

ADOLESCENT; ADULT; CRYOPRESERVATION; EMBRYO TRANSFER; EUROPE; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; NORTH AMERICA; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 84861600800     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.02.038     Document Type: Article

References (25)

1. A. Thurin-Kjellberg, P. Carlsson, and C. Bergh Randomized single versus double embryo transfer: obstetric and paediatric outcome and a cost-effectiveness analysis Hum Reprod 21 2006 210 216
2. P. Devroey, R. Boostanfar, N.P. Koper, B.M.J.L. Mannaerts, P.C. Ijzerman-Boon, B.C.J.M. Fauser Engage Investigators A double-blind, noninferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol Hum Reprod 24 2009 3063 3072
3. J.K. Min, S.A. Breheny, V. MacLachlan, and D.L. Healy What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction Hum Reprod 19 2004 3 7
4. J.C. Arce, A. Nyboe Andersen, and J. Collins Resolving methodological and clinical issues in the design of efficacy trials in assisted reproductive technologies: a mini-review Hum Reprod 20 2005 1757 1771
5. B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baird Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency Hum Reprod Update 15 2009 309 321
6. B.C. Fauser, M.M. Alper, W. Ledger, W.B. Schoolcraft, A. Zandvliet, B.M. Mannaerts Engage Investigators Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF Reprod Biomed Online 21 2010 593 601
7. N. Gleicher, A. Weghofer, and D. Barad A formal comparison of the practice of assisted reproductive technologies between Europe and the USA Hum Reprod 21 2006 1945 1950
8. N. Gleicher, A. Weghofer, and D. Barad Update on the comparison of assisted reproduction outcomes between Europe and the USA: the 2002 data Fertil Steril 87 2007 1301 1305
9. V.L. Baker, C.E. Jones, B. Cometti, F. Hoehler, B. Salle, and J. Urbancsek Factors affecting success rates in two concurrent clinical IVF trials: an examination of potential explanations for the difference in pregnancy rates between the United States and Europe Fertil Steril 94 2010 1287 1291
10. J.M. Gerris Single embryo transfer and IVF/ICSI outcome: a balanced appraisal Hum Reprod Update 11 2005 105 121
11. G. Scotland, D. McLernon, J. Kurinczuk, P. McNamee, K. Harrild, and H. Lyall Minimising twins in in vitro fertilisation: a modelling study assessing the costs, consequences and cost-utility of elective single versus double embryo transfer over a 20-year time horizon Br J Obstet Gynecol 118 2011 1073 1083
12. M.P. Connolly, S. Hoorens, G.M. Chambers ESHRE Reproduction and Society Task Force The costs and consequences of assisted reproductive technology: an economic perspective Hum Reprod Update 16 2010 603 613
13. I.J. Duijkers, C. Klipping, P.J. Boerrigter, C.S. Machielsen, J.J. de Bie, and G. Voortman Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females Hum Reprod 17 2002 1987 1993
14. P. Devroey, B.C. Fauser, P. Platteau, N.G. Beckers, M. Dhont, and B.M. Mannaerts Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization J Clin Endocrinol Metab 89 2004 2062 2070
15. B.M.J.L. Mannaerts, B. Fauser, N. Lahlou, J. Harlin, Z. Shoham, and H. Coelingh Bennink Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy Hum Reprod Update 2 1996 153 161
16. N.S. Macklon, R.L. Stouffer, L.C. Giudice, and B.C.J.M. Fauser The science behind 25 years of ovarian stimulation for IVF Endocr Rev 27 2006 170 207
17. Z. Shoham The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation Fertil Steril 77 2002 1170 1177
18. G. Griesinger, and D.B. Shapiro Luteinizing hormone add-back: is it needed in controlled ovarian stimulation, and if so, when? J Reprod Med 56 2001 279 300
19. Nyboe Andersen A, Pellicer A, Devroey P, Arce JC. A randomized trial (MEGASET) comparing highly purified menotropin and recombinant FSH in a GnRH antagonist cycle with single blastocyst transfer. 27th annual meeting of the European Society for Human Reproduction and Embryology, July 3-6, 2011; Stockholm, Sweden: O-296.
20. K.J. Doody, P. Devroey, A. Leader, H. Witjes, and B.M. Mannaerts No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part 1, corifollitropin alfa Reprod Biomed Online 23 2011 449 456
21. G. Griesinger, D.B. Shapiro, E.M. Kolibianakis, H. Witjes, and B.M. Mannaerts No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH Reprod Biomed Online 23 2011 457 465
22. T. Mardešič, M. Abuzeid, H. Witjes, B. Mannaerts Engage Investigators Success rates of early responders to corifollitropin alfa or daily rFSH in a large, randomized, double-blind trial Hum Reprod 26 Suppl 2011 P469 [abst.]
23. R.J. Norman, F. Zegers-Hochschild, B.S. Salle, J. Elbers, E. Heijnen, M. Marintcheva-Petrova Trust Investigators Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity Hum Reprod 26 2011 2200 2208
24. M. Henman, J.W. Catt, T. Wood, M.C. Bowman, K.A. de Boer, and R.P.S. Jansen Elective transfer of single fresh blastocysts and later transfer of cryostored blastocysts reduces the twin pregnancy rate and can improve the in vitro fertilization live birth rate in younger women Fertil Steril 84 2005 1620 1627
25. H. Selman, G.F. Brusco, F. Fiorini, N. Barnocchi, M. Mariani, and I. El-Danasouri Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome Fertil Steril 91 2009 1611 1613